Accreditation and Claiming Credit: Please review the below accreditation information before proceeding to the post-test and evaluation. The ACCME requires all e-learning activities utilize a post-test. Once you complete the evaluation, you certificate of completion will be automatically generated.
This activity is designed for surgeons. Upon completion of this course, participants should be able to:
ORIGINAL DATE OF RELEASE
April 29, 2019
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. Therefore, it is mandatory that both the program planning committee and speakers complete disclosure forms. Individuals were required to disclosure all commercial relationships prior to their participation in the activity. The ACCME defines a ‘commercial interest’ as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients”. It does not consider providers of clinical service directly to patients to be commercial interests. The ACCME considers “relevant” financial relationships as financial transactions (in any amount) that may create a conflict of interest and occur within the 12 months preceding the time that the individual is being asked to assume a role controlling content of the educational activity.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias. The planning committee members and speakers were contacted and the conflicts listed below have been managed to our satisfaction. However, if you perceive a bias, please advise us of the circumstances on the session evaluation form.
Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage.
The requirement for disclosure is not intended to imply any impropriety of such relationships, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the educational activity.
|SPEAKERS / MODERATORS / CHAIR / DISCUSSANTS||NOTHING TO DISCLOSE||DISCLOSURE
(As it pertains to the presentation)
|John Rioux, MD
Chair / Moderator
|Andrea L. Pusic, MD, MHS, FACS, FRCSC||QPROMS licensing fees – Co-Developer|
|PLANNING COMMITTEE||NOTHING TO DISCLOSE||DISCLOSURE
(All commercial relationships)
|John Rioux, MD||X|
Florida Chapter Member Login